Turning AI skeptics into AI advocates through high-integrity data
With 89% of AI pilots failing to scale, biopharmas can move from data skepticism to advocacy by building a trusted, globally harmonized foundation. By Sebastian Wurst, Director of OpenData Strategy, Veeva Systems
